Acquired atrophy of ovary
ICD-10 N83.31 is a billable code used to indicate a diagnosis of acquired atrophy of ovary.
Acquired atrophy of the ovary refers to the pathological reduction in the size and function of the ovarian tissue, which can occur due to various factors such as hormonal imbalances, surgical interventions, or chronic conditions. This condition may be associated with endometriosis, where ectopic endometrial tissue can lead to inflammation and subsequent ovarian damage. Additionally, female genital prolapse and fistulas can contribute to compromised ovarian blood supply, exacerbating atrophy. Ovarian disorders, including polycystic ovary syndrome (PCOS) and premature ovarian failure, may also play a role in the development of acquired atrophy. Clinically, patients may present with symptoms such as irregular menstrual cycles, infertility, or hormonal imbalances. Diagnosis typically involves imaging studies, hormonal assessments, and a thorough clinical history to identify underlying causes. Understanding the multifactorial nature of acquired atrophy is crucial for effective management and treatment planning.
Detailed surgical history, hormonal assessments, and imaging results.
Patients with endometriosis presenting with ovarian pain, infertility evaluations.
Ensure clear documentation of the relationship between acquired atrophy and any surgical interventions.
Comprehensive hormonal profiles and fertility assessments.
Patients with irregular menstrual cycles and infertility due to ovarian dysfunction.
Document the impact of hormonal treatments on ovarian function.
Used in cases where acquired atrophy is secondary to endometriosis requiring surgical intervention.
Document the extent of endometriosis and any ovarian involvement.
Gynecologists should ensure clear documentation of the surgical findings related to ovarian atrophy.
Common causes include hormonal imbalances, surgical removal of ovarian tissue, chronic inflammatory conditions like endometriosis, and age-related changes.
